4D Molecular Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 4.30 M | $32.27 M | 4.23% | 7.67% |
| BLACKROCK, INC. | 02/12/2026 | 4.06 M | $30.49 B | 5.06% | 7.24% |
| VANGUARD GROUP INC | 01/29/2026 | 3.09 M | $23.20 M | 20.13% | 5.51% |
| STATE STREET CORP | 02/13/2026 | 2.69 M | $20.17 M | 197.52% | 4.79% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 1.94 M | $14.52 M | 76.64% | 3.45% |
| FEDERATED HERMES, INC. | 02/12/2026 | 1.61 M | $12.07 M | 0.92% | 2.87% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.01 M | $7.59 M | 10.78% | 1.80% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 832.59 K | $6.24 M | 1.63% | 1.48% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 704.21 K | $5.28 M | 29.61% | 1.25% |
| MORGAN STANLEY | 02/13/2026 | 672.70 K | $5.05 M | -19.53% | 1.20% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 512.90 K | $3.85 M | 63.77% | 0.91% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 503.43 K | $3.78 M | 151.72% | 0.90% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 477.51 K | $3.58 M | 1.32% | 0.85% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 353.39 K | $2.65 M | 15.54% | 0.63% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 337.50 K | $2.53 M | 23.40% | 0.60% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 296.20 K | $2.22 M | -55.37% | 0.53% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 294.84 K | $2.21 M | 408.29% | 0.53% |
| JPMORGAN CHASE & CO | 02/11/2026 | 279.51 K | $2.10 M | -45.57% | 0.50% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 275.30 K | $2.06 M | -49.92% | 0.49% |
| PEAPOD LANE CAPITAL LLC | 01/28/2026 | 268.02 K | $2.01 M | -16.78% | 0.48% |
| UBS GROUP AG | 01/29/2026 | 231.29 K | $1.73 M | 143.72% | 0.41% |
| JANE STREET GROUP, LLC | 02/12/2026 | 224.90 K | $1.69 M | 92.36% | 0.40% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/03/2026 | 210.00 K | $1.58 M | 6.35% | 0.37% |
| BARCLAYS PLC | 02/13/2026 | 170.64 K | $1.28 M | 81.86% | 0.30% |
| NUVEEN, LLC | 02/12/2026 | 158.77 K | $1.19 B | 69.05% | 0.28% |
| PERIGON WEALTH MANAGEMENT, LLC | 01/16/2026 | 146.13 K | $1.10 M | 0.00% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 136.74 K | $1.03 M | -3.51% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 126.01 K | $945.10 K | -5.12% | 0.22% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 100.00 K | $750.00 K | 100.00% | 0.18% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 96.36 K | $722.73 K | -91.62% | 0.17% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 71.72 K | $537.91 K | 53.13% | 0.13% |
| XTX TOPCO LTD | 02/17/2026 | 65.02 K | $487.67 M | 62.62% | 0.12% |
| RHUMBLINE ADVISERS | 02/13/2026 | 53.85 K | $403.83 K | -16.10% | 0.10% |
| PRINCIPIA WEALTH ADVISORY, LLC | 02/10/2026 | 53.67 K | $402.51 K | 100.00% | 0.10% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 50.76 K | $380.72 K | 100.00% | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 50.00 K | $375.00 K | 0.00% | 0.09% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2026 | 46.98 K | $352.34 K | 0.00% | 0.08% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 46.62 K | $349.65 K | 50.44% | 0.08% |
| DECHENG CAPITAL LLC | 02/12/2026 | 44.31 K | $332.33 K | -52.22% | 0.08% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 36.08 K | $270.63 K | 0.50% | 0.06% |
| CITADEL ADVISORS LLC | 02/17/2026 | 35.30 K | $264.75 K | 52.16% | 0.06% |
| JUMP FINANCIAL, LLC | 02/17/2026 | 33.83 K | $253.73 K | 100.00% | 0.06% |
| TUDOR INVESTMENT CORP ET AL | 02/17/2026 | 31.82 K | $238.61 K | 23.47% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 31.50 K | $236.25 K | 37.55% | 0.06% |
| PROFUND ADVISORS LLC | 02/06/2026 | 30.85 K | $231.38 K | 100.00% | 0.06% |
| AXQ CAPITAL, LP | 02/10/2026 | 30.76 K | $230.66 K | 138.80% | 0.05% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 30.13 K | $225.00 K | -45.32% | 0.05% |
| DEKABANK DEUTSCHE GIROZENTRALE | 01/28/2026 | 30.00 K | $1.17 M | 0.00% | 0.05% |
| HARBOR CAPITAL ADVISORS, INC. | 01/20/2026 | 29.72 K | $223.00 K | 149.69% | 0.05% |
| THRIVENT FINANCIAL FOR LUTHERANS | 02/05/2026 | 28.94 K | $217.00 K | 100.00% | 0.05% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
4D Molecular Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 133 institutional investors and hedge funds held shares of 4D Molecular Therapeutics Inc. The most heavily invested institutionals were:
GOLDMAN SACHS GROUP INC: 4.3 M
BlackRock, Inc.: 4.06 M
VANGUARD GROUP INC: 3.09 M
STATE STREET CORP: 2.69 M
ARMISTICE CAPITAL, LLC: 1.94 M
FEDERATED HERMES, INC.: 1.61 M
94.87% of 4D Molecular Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 32.71 M shares in the last 24 months. This purchase volume represents approximately $299.93 M in transactions.